HCA Healthcare, Inc.
For the period ended Jun 30, 2025. Filed Aug 4, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 4, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unregistered Sales of Equity Securities and Use of Proceeds
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
During January 2025, our Board of Directors authorized a share repurchase program for up to $10 billion of our outstanding common stock. During the quarter ended June 30, 2025, we repurchased 7,031,368 shares of our common stock at an average price of $356.35 per share through market purchases pursuant to the January 2025 authorization. At June 30, 2025, we had $5.753 billion of repurchase authorization available under the January 2025 authorization.
The following table provides certain information with respect to our repurchases of common stock from April 1, 2025 through June 30, 2025 (dollars in billions, except per share amounts).
| Period | Total Numberof SharesPurchased | Average PricePaid per Share | Total Numberof SharesPurchased asPart ofPubliclyAnnouncedPlans orPrograms | ApproximateDollar Value ofShares ThatMay Yet BePurchasedUnder PubliclyAnnounced Plansor Programs |
|---|---|---|---|---|
| April 1, 2025 - April 30,2025 | 2,739,878 | $335.54 | 2,739,878 | $7.339 |
| May 1, 2025 - May 31, 2025 | 2,427,757 | 364.92 | 2,427,757 | 6.453 |
| June 1, 2025 - June 30, 2025 | 1,863,733 | $375.77 | 1,863,733 | $5.753 |
| Total for second quarter 2025 | 7,031,368 | $356.35 | 7,031,368 |
On July 24, 2025, our Board of Directors declared a quarterly dividend of $0.72 per share on our common stock payable on September 30, 2025 to stockholders of record at the close of business on September 16, 2025. Future declarations of quarterly dividends and the establishment of future record and payment dates are subject to the final determination of our Board of Directors.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.